Articles and Speeches
Using Consent Orders In Mass Tort Litigation
July 21, 2011
Amanda Naes Shelton
, Richard B. North, Jr.
As appeared in Law360
New York (July 20, 2011) -- For varying reasons, both plaintiff and defense counsel continue to explore the precise scope of federal regulations with respect to the redaction of identifying information frequently found in the types of documents at issue in pharmaceutical and medical device actions, typically in the context of mass tort litigation.
Click here to read the full article
